Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2.
D015056:1-Methyl-3-isobutylxanthine / Q000494:pharmacology; D015124:8-Bromo Cyclic Adenosine Monophosphate; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D002772:Cholera Toxin / Q000494:pharmacology; D003035:Cobalt / Q000494:pharmacology*; D005576:Colforsin; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000378:metabolism* / Q000494:pharmacology; D015232:Dinoprostone; D004224:Diterpenes / Q000494:pharmacology; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000494:pharmacology*; D007031:Hypothalamus / Q000502:physiology; D007700:Kinetics; D010446:Peptide Fragments / Q000494:pharmacology*; D010902:Pituitary Gland / Q000187:drug effects / Q000502:physiology*; D011458:Prostaglandins E / Q000494:pharmacology*; D011863:Radioimmunoassay; D051381:Rats; D013004:Somatostatin / Q000031:analogs & derivatives
D000959:Antihypertensive Agents; D004224:Diterpenes; D010446:Peptide Fragments; D011458:Prostaglandins E; D005576:Colforsin; D015124:8-Bromo Cyclic Adenosine Monophosphate; D003035:Cobalt; D013004:Somatostatin; D013006:Growth Hormone; D002772:Cholera Toxin; D013007:Growth Hormone-Releasing Hormone; D000242:Cyclic AMP; C018021:cobaltous chloride; D015232:Dinoprostone; D002118:Calcium; D015056:1-Methyl-3-isobutylxanthine